Bluebird Bio Now Worth $213/Share, Piper Jaffray Says
May 26, 2015 at 10:21 AM EDT
In a report published Tuesday, Piper Jaffray analysts maintained their Overweight rating on bluebird bio, Inc. (NASDAQ: BLUE), while ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.